GENEVA, June 19 -- PARIS SCIENCES ET LETTRES filed a patent application (IB2025/061654) for “COPPER N-HETEROCYCLIC CARBENE COMPOUNDS, COPPER N-HETEROCYCLIC CARBENE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER”. With publication no. WO/2026/105053, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07F 1/08
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....